Literature DB >> 6409646

Raised plasma levels of thromboxane B2 in systemic mastocytosis.

R J Ouwendijk, F J Zijlstra, J H Wilson, I L Bonta, J E Vincent, E Stolz.   

Abstract

Plasma levels of thromboxane B2 and 6-keto-prostaglandin F1 alpha were measured in six patients with systemic mastocytosis. Patients with systemic mastocytosis had significantly higher plasma thromboxane B2 levels (530 +/- 105 pg/ml, mean +/- SEM) than controls (118 +/- 8.2 pg/ml, P less than 0.001) and significantly lower 6-keto-prostaglandin F1 alpha levels (40 +/- 3.1 pg/ml, mean +/- SEM) than controls (49 +/- 1.6 pg/ml, P less than 0.05). The mechanism of the raised plasma thromboxane B2 levels is not clear. One possible explanation is that the high thromboxane levels are secondary to an increased production of leukotrienes C and D, which are constituents of slow reacting substances of anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409646     DOI: 10.1111/j.1365-2362.1983.tb00092.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  2 in total

1.  Effects of long-acting somatostatin analog (SMS 201-995) on eicosanoid synthesis and survival in rats with acute necrotizing pancreatitis.

Authors:  B van Ooijen; C J Tinga; W J Kort; F J Zijlstra; S W Lamberts; J H Wilson
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis.

Authors:  Anne Lise Ferrara; Fabiana Piscitelli; Angelica Petraroli; Roberta Parente; Maria Rosaria Galdiero; Gilda Varricchi; Giancarlo Marone; Massimo Triggiani; Vincenzo Di Marzo; Stefania Loffredo
Journal:  J Immunol Res       Date:  2019-07-01       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.